Literature DB >> 23719163

Reversal of behavioral deficits and synaptic dysfunction in mice overexpressing neuregulin 1.

Dong-Min Yin1, Yong-Jun Chen, Yi-Sheng Lu, Jonathan C Bean, Anupama Sathyamurthy, Chengyong Shen, Xihui Liu, Thiri W Lin, Clifford A Smith, Wen-Cheng Xiong, Lin Mei.   

Abstract

Neuregulin 1 (Nrg1) is a susceptibility gene of schizophrenia, a disabling mental illness that affects 1% of the general population. Here, we show that ctoNrg1 mice, which mimic high levels of NRG1 observed in forebrain regions of schizophrenic patients, exhibit behavioral deficits and hypofunction of glutamatergic and GABAergic pathways. Intriguingly, these deficits were diminished when NRG1 expression returned to normal in adult mice, suggesting that damage which occurred during development is recoverable. Conversely, increase of NRG1 in adulthood was sufficient to cause glutamatergic impairment and behavioral deficits. We found that the glutamatergic impairment by NRG1 overexpression required LIM domain kinase 1 (LIMK1), which was activated in mutant mice, identifying a pathological mechanism. These observations demonstrate that synaptic dysfunction and behavioral deficits in ctoNrg1 mice require continuous NRG1 abnormality in adulthood, suggesting that relevant schizophrenia may benefit from therapeutic intervention to restore NRG1 signaling.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23719163      PMCID: PMC4176764          DOI: 10.1016/j.neuron.2013.03.028

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  76 in total

1.  Hippocampal LTP is accompanied by enhanced F-actin content within the dendritic spine that is essential for late LTP maintenance in vivo.

Authors:  Yugo Fukazawa; Yoshito Saitoh; Fumiko Ozawa; Yasuhiko Ohta; Kensaku Mizuno; Kaoru Inokuchi
Journal:  Neuron       Date:  2003-05-08       Impact factor: 17.173

2.  Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice.

Authors:  Yanghong Meng; Yu Zhang; Vitali Tregoubov; Christopher Janus; Luis Cruz; Mike Jackson; Wei Yang Lu; John F MacDonald; Jay Y Wang; Douglas L Falls; Zhengping Jia
Journal:  Neuron       Date:  2002-07-03       Impact factor: 17.173

Review 3.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

4.  Association of neuregulin 1 with schizophrenia confirmed in a Scottish population.

Authors:  Hreinn Stefansson; Jane Sarginson; Augustine Kong; Phil Yates; Valgerdur Steinthorsdottir; Einar Gudfinnsson; Steinunn Gunnarsdottir; Nicholas Walker; Hannes Petursson; Caroline Crombie; Andres Ingason; Jeffrey R Gulcher; Kari Stefansson; David St Clair
Journal:  Am J Hum Genet       Date:  2002-12-11       Impact factor: 11.025

5.  Neuregulin 1 and susceptibility to schizophrenia.

Authors:  Hreinn Stefansson; Engilbert Sigurdsson; Valgerdur Steinthorsdottir; Soley Bjornsdottir; Thordur Sigmundsson; Shyamali Ghosh; Jon Brynjolfsson; Steinunn Gunnarsdottir; Omar Ivarsson; Thomas T Chou; Omar Hjaltason; Birgitta Birgisdottir; Helgi Jonsson; Vala G Gudnadottir; Elsa Gudmundsdottir; Asgeir Bjornsson; Brynjolfur Ingvarsson; Andres Ingason; Sigmundur Sigfusson; Hronn Hardardottir; Richard P Harvey; Donna Lai; Mingdong Zhou; Daniela Brunner; Vincent Mutel; Acuna Gonzalo; Greg Lemke; Jesus Sainz; Gardar Johannesson; Thorkell Andresson; Daniel Gudbjartsson; Andrei Manolescu; Michael L Frigge; Mark E Gurney; Augustine Kong; Jeffrey R Gulcher; Hannes Petursson; Kari Stefansson
Journal:  Am J Hum Genet       Date:  2002-07-23       Impact factor: 11.025

6.  Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia.

Authors:  R Hashimoto; R E Straub; C S Weickert; T M Hyde; J E Kleinman; D R Weinberger
Journal:  Mol Psychiatry       Date:  2004-03       Impact factor: 15.992

7.  Regulation of ADF/cofilin phosphorylation and synaptic function by LIM-kinase.

Authors:  Yanghong Meng; Hisaaki Takahashi; Jinsong Meng; Yu Zhang; Guijin Lu; Suhail Asrar; Toshikazu Nakamura; Zhengping Jia
Journal:  Neuropharmacology       Date:  2004-10       Impact factor: 5.250

8.  Neuregulin1 downregulates postsynaptic GABAA receptors at the hippocampal inhibitory synapse.

Authors:  Masayoshi Okada; Gabriel Corfas
Journal:  Hippocampus       Date:  2004       Impact factor: 3.899

9.  Association study of neuregulin 1 gene with schizophrenia.

Authors:  J Z Yang; T M Si; Y Ruan; Y S Ling; Y H Han; X L Wang; M Zhou; H Y Zhang; Q M Kong; C Liu; D R Zhang; Y Q Yu; S Z Liu; G Z Ju; L Shu; D L Ma; D Zhang
Journal:  Mol Psychiatry       Date:  2003-07       Impact factor: 15.992

Review 10.  Schizophrenia as a disorder of neurodevelopment.

Authors:  David A Lewis; Pat Levitt
Journal:  Annu Rev Neurosci       Date:  2002-03-22       Impact factor: 12.449

View more
  69 in total

1.  The ketogenic diet increases Neuregulin 1 expression via elevating histone acetylation and its anti-seizure effect requires ErbB4 kinase activity.

Authors:  Jin Wang; Jie Huang; Shan Yao; Jia-Hui Wu; Hui-Bin Li; Feng Gao; Ying Wang; Guo-Bin Huang; Qiang-Long You; Jianhua Li; Xiaohui Chen; Xiang-Dong Sun
Journal:  Cell Biosci       Date:  2021-05-21       Impact factor: 7.133

2.  Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons.

Authors:  A Ledonne; A Nobili; E C Latagliata; V Cavallucci; E Guatteo; S Puglisi-Allegra; M D'Amelio; N B Mercuri
Journal:  Mol Psychiatry       Date:  2014-09-30       Impact factor: 15.992

3.  ERBB3-mediated regulation of Bergmann glia proliferation in cerebellar lamination.

Authors:  Anupama Sathyamurthy; Dong-Min Yin; Arnab Barik; Chengyong Shen; Jonathan C Bean; Dwight Figueiredo; Jin-Xiong She; Wen-Cheng Xiong; Lin Mei
Journal:  Development       Date:  2015-01-06       Impact factor: 6.868

Review 4.  Altering the course of schizophrenia: progress and perspectives.

Authors:  Mark J Millan; Annie Andrieux; George Bartzokis; Kristin Cadenhead; Paola Dazzan; Paolo Fusar-Poli; Jürgen Gallinat; Jay Giedd; Dennis R Grayson; Markus Heinrichs; René Kahn; Marie-Odile Krebs; Marion Leboyer; David Lewis; Oscar Marin; Philippe Marin; Andreas Meyer-Lindenberg; Patrick McGorry; Philip McGuire; Michael J Owen; Paul Patterson; Akira Sawa; Michael Spedding; Peter Uhlhaas; Flora Vaccarino; Claes Wahlestedt; Daniel Weinberger
Journal:  Nat Rev Drug Discov       Date:  2016-03-04       Impact factor: 84.694

5.  Transmembrane protein 108 is required for glutamatergic transmission in dentate gyrus.

Authors:  Hui-Feng Jiao; Xiang-Dong Sun; Ryan Bates; Lei Xiong; Lei Zhang; Fang Liu; Lei Li; Hong-Sheng Zhang; Shun-Qi Wang; Ming-Tao Xiong; Mihir Patel; Alexis M Stranahan; Wen-Cheng Xiong; Bao-Ming Li; Lin Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

6.  Disruption of hippocampal neuregulin 1-ErbB4 signaling contributes to the hippocampus-dependent cognitive impairment induced by isoflurane in aged mice.

Authors:  Xiao-Min Li; Fan Su; Mu-Huo Ji; Guang-Fen Zhang; Li-Li Qiu; Min Jia; Jun Gao; Zhongcong Xie; Jian-Jun Yang
Journal:  Anesthesiology       Date:  2014-07       Impact factor: 7.892

7.  Reversible overexpression of bace1-cleaved neuregulin-1 N-terminal fragment induces schizophrenia-like phenotypes in mice.

Authors:  Xiaoyang Luo; Wanxia He; Xiangyou Hu; Riqiang Yan
Journal:  Biol Psychiatry       Date:  2013-10-05       Impact factor: 13.382

8.  Neuregulin-1 impairs the long-term depression of hippocampal inhibitory synapses by facilitating the degradation of endocannabinoid 2-AG.

Authors:  Huizhi Du; In-Kiu Kwon; Jimok Kim
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

Review 9.  Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Authors:  Lin Mei; Klaus-Armin Nave
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

10.  VPS35 Deficiency or Mutation Causes Dopaminergic Neuronal Loss by Impairing Mitochondrial Fusion and Function.

Authors:  Fu-Lei Tang; Wei Liu; Jin-Xia Hu; Joanna Ruth Erion; Jian Ye; Lin Mei; Wen-Cheng Xiong
Journal:  Cell Rep       Date:  2015-08-28       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.